News
Dr. Aaron Carrithers brings a founder’s mindset and extensive firsthand experience, guiding biotech teams through complicated ...
Plus: Rockville man arrested for filming woman in fitting room at Montgomery mall; Montgomery College launches cybersecurity ...
Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...
From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...
Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...
With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global ...
FBT ETF launched 19 years ago and has delivered exceptional returns compared to the broader Health Care sector. Read why FBT ...
Fierce 15 nominations are open! We're searching for the most innovative, resourceful and visionary biotechs leading the way ...
1d
NDTV Profit on MSNBharat Biotech's cholera vaccine 'Hillchol' clears phase-III trialsBharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III ...
Indian drug cos are increasing their presence in the insulin market. They are competing with multinational corporations.
MarketBeat on MSN2d
4 Biotech Stocks on the Verge of Massive BreakthroughsThe FDA is changing how drugs get approved—and that could unleash a biotech revolution. Dylan Jovine from Behind the Markets shares 4 biotech companies on the verge of explosive breakthroughs, ...
With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results